Date published: 2025-11-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tanshinone I (CAS 568-73-0)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Tanshinon I, Tanshinone A, Tanshinquinone I
Application:
Tanshinone I is a biochemical that displays cytotoxicity against IFN-g production in KLH-primed lymph node cells
CAS Number:
568-73-0
Molecular Weight:
276.29
Molecular Formula:
C18H12O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Tanshinone I is a pigment isolated from the herbal medicine Salvia miltiorrhiza Bunge. Tanshinone I displays cytotoxicity against human macrophages and IFN-g production in KLH-primed lymph node cells. Tanshinone I is a diterpenoid compound. It has demonstrated anti-inflammatory, anti-oxidative, and anti-apoptotic properties.


Tanshinone I (CAS 568-73-0) References

  1. Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers.  |  Jing, X., et al. 2016. Cancer Chemother Pharmacol. 77: 1171-81. PMID: 27100736
  2. Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS-dependent manner.  |  Dun, S. and Gao, L. 2019. J Biochem Mol Toxicol. 33: e22267. PMID: 30506648
  3. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway.  |  Wu, YT., et al. 2019. Eur J Pharmacol. 853: 93-102. PMID: 30878387
  4. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway.  |  Wang, W., et al. 2019. J Cell Mol Med. 23: 6454-6465. PMID: 31293090
  5. Tanshinone I Inhibits IL-1β-Induced Apoptosis, Inflammation And Extracellular Matrix Degradation In Chondrocytes CHON-001 Cells And Attenuates Murine Osteoarthritis.  |  Wang, X., et al. 2019. Drug Des Devel Ther. 13: 3559-3568. PMID: 31686786
  6. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.  |  Zhou, J., et al. 2020. Cell Prolif. 53: e12739. PMID: 31820522
  7. Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells.  |  Zheng, L., et al. 2020. Anticancer Drugs. 31: 601-608. PMID: 32011366
  8. Tanshinone I induces apoptosis and protective autophagy in human glioblastoma cells via a reactive oxygen species‑dependent pathway.  |  Jian, S., et al. 2020. Int J Mol Med. 45: 983-992. PMID: 32124953
  9. Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK/ERK mediated apoptotic pathways.  |  Sun, S., et al. 2021. Braz J Med Biol Res. 54: e10685. PMID: 34037092
  10. Tanshinone I Inhibits Oxidative Stress-Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling.  |  Wu, YT., et al. 2021. Front Pharmacol. 12: 644116. PMID: 34084132
  11. Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2.  |  Huang, Y., et al. 2021. Theranostics. 11: 6891-6904. PMID: 34093860
  12. Tanshinone I inhibits metastasis of cervical cancer cells by inducing BNIP3/NIX-mediated mitophagy and reprogramming mitochondrial metabolism.  |  Cui, S., et al. 2022. Phytomedicine. 98: 153958. PMID: 35124382
  13. Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A.  |  Wu, M., et al. 2022. BMC Complement Med Ther. 22: 110. PMID: 35439976
  14. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.  |  Zhao, J., et al. 2022. Drug Des Devel Ther. 16: 3197-3213. PMID: 36158238

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Tanshinone I, 10 mg

sc-205850
10 mg
$106.00

Tanshinone I, 25 mg

sc-205850A
25 mg
$203.00